Syndol Film-coated Tablets Paracetamol 450 mg Codeine Phosphate Hemihydrate 10 mg Doxylamine succinate 5 mg Caffeine 30 mg Ireland - English - HPRA (Health Products Regulatory Authority)

syndol film-coated tablets paracetamol 450 mg codeine phosphate hemihydrate 10 mg doxylamine succinate 5 mg caffeine 30 mg

sanofi-aventis ireland limited t/a sanofi - paracetamol; codeine phosphate hemihydrate; doxylamine succinate; caffeine - film-coated tablet - 450mg/10mg/5mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

Solpa-Plus Tablets Paracetamol 500 mg Codeine Phosphate Hemihydrate 12.8 mg Ireland - English - HPRA (Health Products Regulatory Authority)

solpa-plus tablets paracetamol 500 mg codeine phosphate hemihydrate 12.8 mg

chefaro ireland dac - paracetamol; codeine phosphate hemihydrate - film-coated tablet - 500 mg/12.8 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

ACETAMINOPHEN AND CODEINE- acetaminophen and codeine phosphate tablet United States - English - NLM (National Library of Medicine)

acetaminophen and codeine- acetaminophen and codeine phosphate tablet

par pharmaceutical, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - codeine phosphate 30 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia, have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated for: • all children younger than 12 years of age [see warnings ]. • post-operative management in children younger than 18 years of age following tonsillectomy and/or aden

PRODEINE FORTE paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

prodeine forte paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: stearic acid; maize starch; pregelatinised maize starch; povidone; magnesium stearate; purified talc; croscarmellose sodium; potassium sorbate; microcrystalline cellulose - prodeine forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

PANAMAX CO paracetamol 500 mg and codeine phosphate hemihydrate 8 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

panamax co paracetamol 500 mg and codeine phosphate hemihydrate 8 mg tablet blister pack

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 8 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: soluble maize starch; povidone; microcrystalline cellulose; stearic acid; potassium sorbate; magnesium stearate; maize starch; purified talc - for the relief of acute moderate pain

Actacode Codeine Linctus (Chloroform-free) codeine phosphate hemihydrate 5 mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

actacode codeine linctus (chloroform-free) codeine phosphate hemihydrate 5 mg/ml oral liquid bottle

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: glycerol; propylene glycol; sucrose; purified water; potassium sorbate; hydrochloric acid; sodium hydroxide; methyl hydroxybenzoate; propyl hydroxybenzoate; ethyl hydroxybenzoate; butyl hydroxybenzoate; isobutyl hydroxybenzoate - relief of unproductive, dry and intractable coughs associated with colds and flu.

CIPLA COLD & FLU DAY TABLETS Paracetamol 500 mg, Pseudoephedrine Hydrochloride 30mg and codeine phosphate hemihydrate 6mg uncoated tablets, blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

cipla cold & flu day tablets paracetamol 500 mg, pseudoephedrine hydrochloride 30mg and codeine phosphate hemihydrate 6mg uncoated tablets, blister pack

cipla australia pty ltd - codeine phosphate hemihydrate, quantity: 6 mg; paracetamol, quantity: 500 mg; pseudoephedrine hydrochloride, quantity: 30 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; maize starch; sodium starch glycollate; microcrystalline cellulose; povidone - temporary symptomatic relief of rhinorrhoea, nasal congestion, headache, myalgia and fever in patient aged 12 years and over.

MEDREICH Paracetamol 500 mg and codeine phosphate hemihydrate 15 mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

medreich paracetamol 500 mg and codeine phosphate hemihydrate 15 mg tablets blister pack

medreich australia pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 15 mg - tablet, uncoated - excipient ingredients: purified water; povidone; potato starch; ethanol; docusate sodium; magnesium stearate; lactose monohydrate; colloidal anhydrous silica - for temporary relief of acute moderate pain.